SCHEMBL6186690

SCHEMBL6186690

O=C1N(Cc2ccccc2)CC(C=CC(O)C(F)(F)c2ccccc2)N1CCCC(F)(F)SCP(=O)(O)O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 14/20 0.34
PTGER3 P43115 5/20 0.34
PTGER2 P43116 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000880 1.00 PTGER4 (0.34) PTGER4PTGER3PTGER2
SCHEMBL6000888 1.00 PTGER4 (0.34) PTGER4PTGER3PTGER2
SCHEMBL5999495 0.89 PTGER4 (0.43) PTGER4PTGER3PTGER2
SCHEMBL5999488 0.89 PTGER4 (0.43) PTGER4PTGER3PTGER2
SCHEMBL5999449 0.88 PTGER4 (0.38) PTGER4PTGER3PTGER2
SCHEMBL5999441 0.88 PTGER4 (0.38) PTGER4PTGER3PTGER2
SCHEMBL6000899 0.88 PTGER4 (0.40) PTGER4PTGER3PTGER2
SCHEMBL6000890 0.88 PTGER4 (0.40) PTGER4PTGER3PTGER2
SCHEMBL6001146 0.86 PTGER4 (0.40) PTGER4PTGER3PTGER2
SCHEMBL6001143 0.86 PTGER4 (0.40) PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513523-A1 1,5-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE AND BONE DISEASES Merck Frosst Canada & Co. (CA) 2005-03-16 EP claimed
WO-2003103664-A1 1,5-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE AND BONE DISEASES MERCK FROSST CANADA & CO. (CA) 2003-12-18 WO claimed